These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protection against Mycobacterium ulcerans lesion development by exposure to aquatic insect saliva. Marsollier L, Deniaux E, Brodin P, Marot A, Wondje CM, Saint-André JP, Chauty A, Johnson C, Tekaia F, Yeramian E, Legras P, Carbonnelle B, Reysset G, Eyangoh S, Milon G, Cole ST, Aubry J. PLoS Med; 2007 Feb 18; 4(2):e64. PubMed ID: 17326707 [Abstract] [Full Text] [Related]
6. Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Stienstra Y, van der Graaf WT, te Meerman GJ, The TH, de Leij LF, van der Werf TS. Trop Med Int Health; 2001 Jul 18; 6(7):554-62. PubMed ID: 11469950 [Abstract] [Full Text] [Related]
10. In the case of transmission of Mycobacterium ulcerans in buruli ulcer disease Acanthamoeba species stand accused. Wilson MD, Boakye DA, Mosi L, Asiedu K. Ghana Med J; 2011 Mar 18; 45(1):31-4. PubMed ID: 21572823 [Abstract] [Full Text] [Related]
14. [Buruli ulcer (Mycobacterium ulcerans infection); report from the International Congress in Yamoussoukro, Ivory Coast]. van der Graaf WT, Scherpbier RW, van der Werf TS. Ned Tijdschr Geneeskd; 1999 Feb 06; 143(6):312-6. PubMed ID: 10221089 [Abstract] [Full Text] [Related]
15. Aquatic insects as a vector for Mycobacterium ulcerans. Marsollier L, Robert R, Aubry J, Saint André JP, Kouakou H, Legras P, Manceau AL, Mahaza C, Carbonnelle B. Appl Environ Microbiol; 2002 Sep 06; 68(9):4623-8. PubMed ID: 12200321 [Abstract] [Full Text] [Related]
17. Buruli ulcer: emerging from obscurity. Wansbrough-Jones M, Phillips R. Lancet; 2006 Jun 03; 367(9525):1849-58. PubMed ID: 16753488 [Abstract] [Full Text] [Related]
18. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Portaels F, Aguiar J, Debacker M, Guédénon A, Steunou C, Zinsou C, Meyers WM. Infect Immun; 2004 Jan 03; 72(1):62-5. PubMed ID: 14688081 [Abstract] [Full Text] [Related]
19. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu E, Amofah G, Asiedu K, Wansbrough-Jones M. Antimicrob Agents Chemother; 2005 Aug 03; 49(8):3182-6. PubMed ID: 16048922 [Abstract] [Full Text] [Related]
20. Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Gooding TM, Johnson PD, Smith M, Kemp AS, Robins-Browne RM. Infect Immun; 2002 Oct 03; 70(10):5562-7. PubMed ID: 12228283 [Abstract] [Full Text] [Related] Page: [Next] [New Search]